Dipeptidyl peptidase‐4 inhibitors‐associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients

Dipeptidyl peptidase‐4 inhibitors‐associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9,304 diabetes mellitus patients

Abstract Aims/Introduction Bullous pemphigoid (BP) might be drug‐induced. The present study evaluated the relationship between BP and dipeptidyl peptidase‐4 inhibitors (DPP4Is). Materials and Methods We recruited patients diagnosed with BP at Ogaki Municipal Hospital from 1 December 2009 through 31...

Full description

Bibliographic Details
Main Authors: Yohei Kawaguchi, Risa Shimauchi, Nobuhiro Nishibori, Kiyohito Kawashima, So Oshitani, Atsushi Fujiya, Taiga Shibata, Norimi Ohashi, Kentaro Izumi, Wataru Nishie, Hiroshi Shimizu, Hiroshi Arima, Hiroshi Sobajima
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:Journal of Diabetes Investigation
Subjects:
Bullous pemphigoid
Dipeptidyl peptidase‐4 inhibitors
Drug side‐effect
Online Access:https://doi.org/10.1111/jdi.12877

Internet

https://doi.org/10.1111/jdi.12877

Similar Items